Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15761592rdf:typepubmed:Citationlld:pubmed
pubmed-article:15761592lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:15761592lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:15761592lifeskim:mentionsumls-concept:C0556025lld:lifeskim
pubmed-article:15761592lifeskim:mentionsumls-concept:C1551421lld:lifeskim
pubmed-article:15761592lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:15761592lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:15761592lifeskim:mentionsumls-concept:C0016253lld:lifeskim
pubmed-article:15761592lifeskim:mentionsumls-concept:C0023937lld:lifeskim
pubmed-article:15761592pubmed:issue8lld:pubmed
pubmed-article:15761592pubmed:dateCreated2005-3-11lld:pubmed
pubmed-article:15761592pubmed:abstractTextIn order to estimate the prevalence of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) co-infection in hard-to-reach intravenous drug users, 199 subjects from high-risk inner-city locales, the so called "shooting galleries", were consented, interviewed, and tested in Miami, FL, US. Positive HIV-1 status was based on repeatedly reactive ELISA and confirmatory Western Blot. Positive HCV status was based on reactive ELISA and confirmatory polymerase chain reaction techniques. Overall, 50 (25%) were not infected with either virus, 61 (31%) were HIV-1/HCV co-infected, 17 (8%) infected by HIV-1 only, and 71 (36%) infected by HCV only. The results of the multivariable analyses showed that more years using heroin was the only significant risk factor for HCV only infection (odds ratio = 1.15; 95% confidence interval = 1.07, 1.24) and for HIV-1/HCV co-infection (odds ratio = 1.17; 95% confidence interval = 1.09, 1.26). This paper demonstrates that HIV-1/HCV co-infection is highly prevalent among so called "shooting galleries".lld:pubmed
pubmed-article:15761592pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15761592pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15761592pubmed:languageenglld:pubmed
pubmed-article:15761592pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15761592pubmed:citationSubsetIMlld:pubmed
pubmed-article:15761592pubmed:statusMEDLINElld:pubmed
pubmed-article:15761592pubmed:monthDeclld:pubmed
pubmed-article:15761592pubmed:issn0074-0276lld:pubmed
pubmed-article:15761592pubmed:authorpubmed-author:MetschLisa...lld:pubmed
pubmed-article:15761592pubmed:authorpubmed-author:McCoyClyde...lld:pubmed
pubmed-article:15761592pubmed:authorpubmed-author:ArheartKristo...lld:pubmed
pubmed-article:15761592pubmed:authorpubmed-author:ShapshakPaulPlld:pubmed
pubmed-article:15761592pubmed:authorpubmed-author:MessiahSarah...lld:pubmed
pubmed-article:15761592pubmed:authorpubmed-author:Collado-MesaF...lld:pubmed
pubmed-article:15761592pubmed:authorpubmed-author:KatzDoloresDlld:pubmed
pubmed-article:15761592pubmed:issnTypePrintlld:pubmed
pubmed-article:15761592pubmed:volume99lld:pubmed
pubmed-article:15761592pubmed:ownerNLMlld:pubmed
pubmed-article:15761592pubmed:authorsCompleteYlld:pubmed
pubmed-article:15761592pubmed:pagination789-93lld:pubmed
pubmed-article:15761592pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:meshHeadingpubmed-meshheading:15761592...lld:pubmed
pubmed-article:15761592pubmed:year2004lld:pubmed
pubmed-article:15761592pubmed:articleTitleThe prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, Florida.lld:pubmed
pubmed-article:15761592pubmed:affiliationDepartment of Epidemiology and Public Health, University of Miami School of Medicine, Highland Professional Building, 801 NW 9th Avenue, Miami, FL 33136, USA. CMcCoy@med.miami.edulld:pubmed
pubmed-article:15761592pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15761592pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15761592pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15761592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15761592lld:pubmed